Transcatheter Interventions Online 2022 - On Demand
Published: 09 March 2022
Part 1 | Session 2 Session 1.2: Live Cases and Discussion
Part 1 | Session 4 Session 1.3: Practical Perspectives in the Context of TAVI
Part 1 | Session 5 Session 1.4: Live Cases and Discussions
Part 1 | Session 6 BREAKOUT: Current Data and Future Direction in LAAC
Part 2 | Session 1 Session 2.1: Strategies for Calcified Coronary Lesions Anno 2022
Part 2 | Session 2 Session 2.2: Live Cases and Discussion
Part 2 | Session 4 Session 2.3: Practical Pearls Towards a More Advanced CTO Programme
Part 2 | Session 5 Session 2.4: Live Cases and Discussion
Part 2 | Session 7 BREAKOUT: Coronary Physiology in STEMI patients today: Why? When? How?
Following on from the success of 2021's inaugural edition, Transcatheter Interventions Online 2022 brings together a world-class faculty to provide expert insight and educational learning on the latest developments in interventional management.
Combining expert opinion and discussion, presentations, and live cases from centres on both sides of the Atlantic, TIO 2022 delivers best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
Note, the live version of this session was CME accredited; this on-demand version is not.
Key Learning Objectives
- Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
- Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
- Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
- Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
- Discuss the need for gender-specific trials and renal denervation
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Day One: Structural Heart Disease
Day Two: Coronary Heart Disease: High Risk & Complex PCI
Day Three: Debates and Controversies
Nicolas M Van Mieghem
From an early age, Professor Nicolas Maria Van Mieghem decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them. I wanted to enter a profession that would channel my energy— I was always a busy child,” he says.
A budding athlete, he was a member of Belgium’s national swimming team but soon realized that medicine was his true calling. His father was a general cardiologist and one of his biggest influences early in his career.
Professor Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002.
His mantra is mens sana in corpore sano (a…
Kendra J Grubb
Dr Kendra Grubb is the surgical director of the structural heart and valve center at Emory Healthcare. She is also an associate professor of surgery at Emory University School of Medicine.
Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centered approach to the treatment of cardiovascular disease.
After obtaining her BS in Biology from the University of Southern California (1999), Kendra attended the University of Southern California, where she received her a master’s in health administration from the Sol Price School of Public Policy (2001), followed by an MD degree at the Keck School of Medicine (2005).
She pursued a general surgery residency at the University of Illinois at Chicago between 2005 and 2010, a fellowship in…
Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).
Section Head of Interventional Cardiology
Dr Mohamed Azeem Latib is a world-leading expert in Interventional Cardiology.
In his free time, he loves the outdoors and being in nature with his family. He speaks English, Italian and Afrikaans.
Azeem is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).
In 1995, Azeem obtained his M.D. from University of the Witwatersrand, Johannesburg and did his Residency in Cardiology at Groote Schuur Hospital, Cape Town, South Africa. He did his Internal Medicine Internship at the Groote Schuur Hospital and his Interventional Cardiology Fellowship at the San Raffaele Scientific Institute & University Vita Salute, Milan, Italy.1
He completed a fellowship with the College of Physicians of South Africa in 2002, followed by a certificate in cardiology from the…
Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and, with more than 20 years experience of Interventional Cardiology, is considered one of the country's leading experts in management of Cardiovascular complaints.
A pioneer of Interventional Cardiology, David is recognised internationally as a leader in cardiovascular diagnosis and treatment.